Portfolio
The NeuroTechnology Partners Fund gives investor access to participate in the value created by the more than 300 physician leaders in the NTI network. These physicians identify, vet and support the development of innovative medical technologies and promising business models. The current NTI Partners Fund portfolio includes:
Neurotechnology to address the limitations of the human body. The world’s first minimally invasive brain computer interface.
Developing neurovascular therapies for venous stenosis.
Developing the Endoport Vacuum Assisted Collection (EVAC™) for subdural hematoma drainage
A patented new catheter platform for vascular access to obsolete the current design standard
Future Portfolio Candidates
Developing actuable mechatronic guide wire for endovascular access and navigation
Developing navigational microcatheters with 3D, controlled steering
Detection, differentiation and management of neurological disease (Parkinson’s, Alzheimer’s and TBI) through non-invasive collection of objective data from the eyes (blink reflex)
Developing intrasaccular flow diverters for treatment of brain aneurysms
Developing Cerebrovascular Protective Therapeutics
Providing tech-enabled healthcare services to improve outcomes for stroke survivors and healthcare stakeholders
Crowdfunding and open-source contribution for medical research
Sim&Size™ software that uses patient-specific 3d Modeling to visualize the placement of devices dedicated to the treatment of intracranial aneurysms
Stroke Diagnostics, LLC
Developing portable, fast and accurate triage tools for Brain health Developed in partnership with the Jacobs Institute
